Superficial X-ray therapy remains a viable treatment for primary basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) in select patients. Menu SECTIONS.

Compr Ophthalmol Update. 2007;8(1):1-14. The micronodular (. 15%) variant shows smaller tumor nodules (< 0.15 mm by definition) (Figure 1C) and has an increased tendency for subclinical extension ...

In this study, 187 patients with one or more superficial basal cell carcinoma were randomly assigned to receive photodynamic therapy with Ameluz or placebo, according to the release. Both groups ...

Superficial basal cells are much more ... If the pathology report describes the ... Sekulic A, Migden MR, Oro AE, et al. Efficacy and safety of vismodegib in advanced basal-cell carcinoma.

Biofrontera Inc. Announces Highly Significant Results In Phase 3 Study Of Ameluz®-Photodynamic Therapy (PDT) Regarding The Treatment Of Superficial Basal Cell Carcinoma (sBCC) Biofrontera Inc ...

In this study, researchers treated 37 basal cell carcinoma (BCC) lesions from 30 patients, with follow-ups at 5 time points after baseline examination. A novel nonthermal bioelectric treatment ...

The phase 3 study of Ameluz and RhodoLED photodynamic therapy for superficial basal cell carcinoma has reached a key milestone as the final patient has completed the 1-year follow-up visit.

Ressler, J. M., et al. (2025) Efficacy and tolerability of neoadjuvant therapy with Talimogene laherparepvec in cutaneous basal cell carcinoma: a phase II trial (NeoBCC trial).Nature Cancer.doi ...